IRIS
ZANGHI', Mariangela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.204
EU - Europa 1.163
AS - Asia 325
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 2.697
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.202
SE - Svezia 307
IE - Irlanda 288
IT - Italia 218
CN - Cina 189
SG - Singapore 107
UA - Ucraina 80
DE - Germania 58
GB - Regno Unito 48
PL - Polonia 47
FI - Finlandia 40
FR - Francia 38
BE - Belgio 22
IN - India 18
RU - Federazione Russa 5
NO - Norvegia 4
IR - Iran 3
BG - Bulgaria 2
JP - Giappone 2
RO - Romania 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CA - Canada 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EU - Europa 1
HR - Croazia 1
ID - Indonesia 1
KG - Kirghizistan 1
LT - Lituania 1
MX - Messico 1
NZ - Nuova Zelanda 1
TH - Thailandia 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 2.697
Salva come PNG Salva come JPEG
Città #
Dublin 287
Chandler 212
Nyköping 169
Jacksonville 164
Singapore 83
Ashburn 76
Ann Arbor 72
Beijing 72
Dearborn 47
Warsaw 47
New York 44
Medford 40
Princeton 40
Cambridge 39
Messina 39
Des Moines 33
Boardman 29
Woodbridge 23
Brussels 22
Lancaster 19
San Mateo 17
Jinan 15
Wilmington 14
Pune 12
Hebei 11
Tianjin 11
Zhengzhou 10
Houston 9
Los Angeles 9
Nanjing 9
Shenyang 8
Taizhou 8
Nanchang 6
Ningbo 6
Seattle 6
Hangzhou 5
Leawood 5
Monmouth Junction 5
Auburn Hills 4
Augusta 4
Jiaxing 4
Bremen 3
Brockport 3
Changsha 3
Genova 3
Guangzhou 3
Las Vegas 3
London 3
Milan 3
Norwalk 3
Oslo 3
Rome 3
Taiyuan 3
Trepuzzi 3
Brooklyn 2
Catania 2
Clearwater 2
Dong Ket 2
Forestella 2
Fort Washington 2
Fuzhou 2
Girifalco 2
Grammichele 2
Haikou 2
Hyderabad 2
Lanzhou 2
Melito Irpino 2
Montalbano 2
Novokuznetsk 2
Rüsselsheim 2
Sassari 2
Stockholm 2
Torino 2
Villar Perosa 2
Acireale 1
Ardabil 1
Beinasco 1
Bergamo 1
Birmingham 1
Bishkek 1
Bologna 1
Brescia 1
Brno 1
Calderara Di Reno 1
Cardano 1
Castell'arquato 1
Changle 1
Chicago 1
Copenhagen 1
Dallas 1
Dunedin 1
Edinburgh 1
Frankfurt am Main 1
Hefei 1
Helsinki 1
Islington 1
Jakarta 1
Jeffries 1
Johannesburg 1
Kunming 1
Totale 1.840
Salva come PNG Salva come JPEG
Nome #
Linfoscintigrafia ascellare preoperatoria nel cancro della mammella. 241
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives 107
zd1839"iressa" in heavily pretreated patients with advaned/metastatic non-small cell lung cancer(NSCLC):assessment of tolerability and the clinical benefit 88
Beta=interferon in the treatment of 14 patie nts with advanced colorectal carcinoma. J Exp Pathol. 1987 Summer;3(4):603-5. No abstract available. PMID: 3454807 [PubMed - indexed for MEDLINE] 83
Epirubucin (EPI) and Paclitaxel (TAX) in advanced breast cancer.a phase II studyi 83
NSCLC and HER2: between lights and shadows 83
Second line chemoterapy in patients with metastatic colorectal cancer(MCRC):our experience 81
Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we going 79
LINFOSCINTIGRAFIA ASCELLARE PREOPERATORIA DEL CANCRO DELLA MAMMELLA. Acta Oncologica - Voi. XVI – n. 1, 1995. 75
ZD 1839 IRESSA IN HEAVILY PRETREATED PATIENTS WITH ADVANCED/METASTATIC NON SMALL CELL LUNG CANCER:ASSESSMENT OF TOLERABILITY AND CLINICAL BENEFIT 73
Second-line therapy in advanced non-small cell lung cancer: Cytotoxic agents or tyrosine kinase inhibitors? Our experience. 71
INCIDENZA DELL'ONCOTIPO POLMONARE NELLO STESSO TERRITORIO IN TRIENNI DIFFERENTI- 1983/84/85 E 1993/94/95. Eur. Jour. of Oncology Vol. 2, n° 4, 1997. 69
Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: A phase II study 69
Gemcitabine (GEM) and cisplatin (CIS) in advanced/metastatic transitional cell carcinoma (TCC) of bladder:phase II study 69
May the istotype influence the response to pemetrexed in patients with non small cell lung cancer? Preliminary data of our clinical experience. 67
gemcitabine and pegylated liposomial doxorubicin in recurrent epithelial ovarian cancer (REOC).Preliminary report a phase II study 67
Androgen receptor (AR), E-cadherin, and Ki-67 as prognostic markers in triple-negative breast cancer (TNBC). 66
A new method for titration of oral transmucosal fentanyl citrate (OTFC) starting dose in cancer patients. 65
Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: a phase II study. J Chemother. 1999 Feb;11(1):74-7. PMID: 10078785 [PubMed - indexed for MEDLINE] 65
OUR EXPERIENCE ON THE EFFECTS OF TAMOXIFEN ON BLOOD COAGULATION IN PATIENTS OPERATED FOR BREAST CANCER Folia Oncologica vol.XIV-n.2-3 (Aprile-Settembre)-1991 64
Gemcitabine (GEM) and cisplatin (Cis) in advanced/metastatic transitional cell carcinoma (TCC) of bladder: Phase II study 64
A PHASE II STUDY (21 DAY REGIMEN) OF GEMCITABINE AND CISPLATIN IN TRANSITIONAL CELL CARCINOMA OF BLADDER 64
Predicting sensitivity of non small cell lung cancer to gefitinib and erlotinib: is there still a role for clinical factors ? 62
Safety of trastuzumab, alone or in combination, in elderly patients with HER2-positive breast cancer: A 5-year case series. 58
Dati preliminari sulla caratterizzazione molecolare dei casi di melanoma familiare di origine siciliana. 56
Dati preliminari sulla caratterizzazione molecolare dei casi di melanoma familiare di origine siciliana. 56
Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: Updated results and long-term survival. 55
Incidenza dell’oncotipo polmonare nello stesso territorio in trienni differenti 1983/84/85 e 1993/94/95. 55
Safety of Zoledronic acid in bone metastatic breast cancer patients: A retrospective analysis. 54
Induction chemotherapy to weekly paclitaxel concurrent with curative radiotherapy in stage IV (MO) unresectable head and neck squamous cell carcinoma: a dose escalation study 54
PHASE II STUDY OF LIPOSOMAL DOXORUBICIN AND GEMCYTABINE IN THE TREATMENT OF RECURRENT OVARIAN CANCER 53
Impact of single-nucleotide polymorphisms in genes coding for folate pathway enzymes on efficacy/toxicity of gemcitabine and pemetrexed based therapy in advanced non small cell lung cancer (NSCLC): new prospectives for old markers. 53
Correlation between serum magnesium levels and skin toxicity during cetuximab treatment in squamous cell carcinoma of head and neck cancer (SCCHN): the role of weekly intravenous magnesium supplementation. 53
Dati preliminari sulla caratterizzazione molecolare dei casi di melanoma familiare di origine siciliana. 52
IL-33/IL-31 axis: A new pathological mechanism for epidermal growth factor receptor tyrosine kinase inhibitors-associated skin toxicity? 52
Overview and new strategies in metastatic breast cancer (MBC) for treatment of tamoxifen-resistant patients. 51
Role of Androgen Receptor (AR), Ki 67 and E-cadherin as prognostic markers in Triple Negative Breast Cancer (TNBC) 50
Molecular and clinical analysis of predictive biomarkers to anti-EGFR inhibitors in metastatic colorectal cancer (mCRC): Interaction among early tumor shrinkage, skin toxicities, and RAS status. 46
Safety of trastuzumab-containing therapies in elderly women with metastatic breast cancer. 42
null 22
The risk of toxicities from trastuzumab, alone or in combination, in an elderly breast cancer population. 15
Totale 2.732
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.177
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.177
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020245 0 0 0 0 0 52 38 39 5 48 54 9
2020/2021373 35 5 97 28 23 30 17 24 11 37 51 15
2021/2022332 4 57 6 10 6 1 25 9 3 86 40 85
2022/2023879 70 93 39 68 65 77 7 69 363 0 20 8
2023/2024227 20 42 7 24 12 81 14 14 0 4 0 9
2024/2025130 6 7 14 52 27 24 0 0 0 0 0 0
Totale 2.732